Clinical Trial Update: Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

Completed Phase 3 clinical trial evaluating a bendamustine/gemcitabine/vinorelbine regimen in relapsed/refractory classical Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)
• Treanda (Bendamustine)

Snippet

Sponsor: Cairo University | Conditions: Classical Hodgkin Lymphoma Relapsed | Phase 3 | Status: COMPLETED